Matches in SemOpenAlex for { <https://semopenalex.org/work/W2980471240> ?p ?o ?g. }
- W2980471240 endingPage "862" @default.
- W2980471240 startingPage "851" @default.
- W2980471240 abstract "Deletion and mutation of the Smad4 gene are favorable events for the progression of colon cancer, which is related to the negative regulation of vascular endothelial growth factor C (VEGF-C). However, the regulatory mechanism between Smad4 and VEGF-C remains unclear. We reported first that Smad4 can increase the transcription of miR-128-3p, a microRNA targeting VEGF-C mRNA, resulting in a negative correlation between Smad4 and VEGF-C. Moreover, we found that Smad4 combined with Smad3 can positively regulate VEGF-C during colon cancer metastasis through binding to VEGF-C gene promoter. Further, results revealed a mechanism that long noncoding RNA (lncRNA) ASLNC07322 increased specifically in metastatic colon cancer and decreased miR-128-3p as a sponge, leading to a subsequent elevation of VEGF-C. In a word, there are two pathways in the progression of colon cancer, including Smad4/miR-128-3p/VEGF-C and Smad4/VEGF-C pathways in non-metastatic and metastatic colon cancer, respectively. ASLNC07322 crucially controlled this negative and positive regulatory transformation between them. Additionally, ASLNC07322 knockdown combined with Smad4 overexpression could efficiently inhibit lymphatic endothelial cells (LECs) proliferation and tube formation in vitro, as well as tumor growth and lymphangiogenesis in vivo. These data explained the underlying mechanism of Smad4 contribution on VEGF-C expression during metastasis where ASLNC07322 functions vitally as a switch in colon cancer. Deletion and mutation of the Smad4 gene are favorable events for the progression of colon cancer, which is related to the negative regulation of vascular endothelial growth factor C (VEGF-C). However, the regulatory mechanism between Smad4 and VEGF-C remains unclear. We reported first that Smad4 can increase the transcription of miR-128-3p, a microRNA targeting VEGF-C mRNA, resulting in a negative correlation between Smad4 and VEGF-C. Moreover, we found that Smad4 combined with Smad3 can positively regulate VEGF-C during colon cancer metastasis through binding to VEGF-C gene promoter. Further, results revealed a mechanism that long noncoding RNA (lncRNA) ASLNC07322 increased specifically in metastatic colon cancer and decreased miR-128-3p as a sponge, leading to a subsequent elevation of VEGF-C. In a word, there are two pathways in the progression of colon cancer, including Smad4/miR-128-3p/VEGF-C and Smad4/VEGF-C pathways in non-metastatic and metastatic colon cancer, respectively. ASLNC07322 crucially controlled this negative and positive regulatory transformation between them. Additionally, ASLNC07322 knockdown combined with Smad4 overexpression could efficiently inhibit lymphatic endothelial cells (LECs) proliferation and tube formation in vitro, as well as tumor growth and lymphangiogenesis in vivo. These data explained the underlying mechanism of Smad4 contribution on VEGF-C expression during metastasis where ASLNC07322 functions vitally as a switch in colon cancer." @default.
- W2980471240 created "2019-10-25" @default.
- W2980471240 creator A5003396938 @default.
- W2980471240 creator A5003753200 @default.
- W2980471240 creator A5026214343 @default.
- W2980471240 creator A5031976013 @default.
- W2980471240 creator A5033636135 @default.
- W2980471240 creator A5034608423 @default.
- W2980471240 creator A5064478014 @default.
- W2980471240 creator A5072594515 @default.
- W2980471240 creator A5073628100 @default.
- W2980471240 date "2019-12-01" @default.
- W2980471240 modified "2023-10-02" @default.
- W2980471240 title "Long Noncoding RNA ASLNC07322 Functions in VEGF-C Expression Regulated by Smad4 during Colon Cancer Metastasis" @default.
- W2980471240 cites W1968655535 @default.
- W2980471240 cites W1971054115 @default.
- W2980471240 cites W2062537719 @default.
- W2980471240 cites W2075201743 @default.
- W2980471240 cites W2085581448 @default.
- W2980471240 cites W2093791846 @default.
- W2980471240 cites W2110957978 @default.
- W2980471240 cites W2116168949 @default.
- W2980471240 cites W2153882021 @default.
- W2980471240 cites W2164100413 @default.
- W2980471240 cites W2171797570 @default.
- W2980471240 cites W2239877427 @default.
- W2980471240 cites W2412814044 @default.
- W2980471240 cites W2466805359 @default.
- W2980471240 cites W2471420007 @default.
- W2980471240 cites W2601673178 @default.
- W2980471240 cites W2609025521 @default.
- W2980471240 cites W2660411982 @default.
- W2980471240 cites W2756233238 @default.
- W2980471240 cites W2767839269 @default.
- W2980471240 cites W2793799789 @default.
- W2980471240 cites W2801173103 @default.
- W2980471240 cites W2808631186 @default.
- W2980471240 cites W2889641416 @default.
- W2980471240 cites W2890752591 @default.
- W2980471240 cites W2901037514 @default.
- W2980471240 cites W2915478882 @default.
- W2980471240 doi "https://doi.org/10.1016/j.omtn.2019.10.012" @default.
- W2980471240 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6861657" @default.
- W2980471240 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31739210" @default.
- W2980471240 hasPublicationYear "2019" @default.
- W2980471240 type Work @default.
- W2980471240 sameAs 2980471240 @default.
- W2980471240 citedByCount "14" @default.
- W2980471240 countsByYear W29804712402020 @default.
- W2980471240 countsByYear W29804712402021 @default.
- W2980471240 countsByYear W29804712402022 @default.
- W2980471240 countsByYear W29804712402023 @default.
- W2980471240 crossrefType "journal-article" @default.
- W2980471240 hasAuthorship W2980471240A5003396938 @default.
- W2980471240 hasAuthorship W2980471240A5003753200 @default.
- W2980471240 hasAuthorship W2980471240A5026214343 @default.
- W2980471240 hasAuthorship W2980471240A5031976013 @default.
- W2980471240 hasAuthorship W2980471240A5033636135 @default.
- W2980471240 hasAuthorship W2980471240A5034608423 @default.
- W2980471240 hasAuthorship W2980471240A5064478014 @default.
- W2980471240 hasAuthorship W2980471240A5072594515 @default.
- W2980471240 hasAuthorship W2980471240A5073628100 @default.
- W2980471240 hasBestOaLocation W29804712401 @default.
- W2980471240 hasConcept C103041312 @default.
- W2980471240 hasConcept C104317684 @default.
- W2980471240 hasConcept C121608353 @default.
- W2980471240 hasConcept C145059251 @default.
- W2980471240 hasConcept C146285616 @default.
- W2980471240 hasConcept C165864922 @default.
- W2980471240 hasConcept C167734588 @default.
- W2980471240 hasConcept C173396325 @default.
- W2980471240 hasConcept C2776636583 @default.
- W2980471240 hasConcept C2777025900 @default.
- W2980471240 hasConcept C2779013556 @default.
- W2980471240 hasConcept C2779256057 @default.
- W2980471240 hasConcept C502942594 @default.
- W2980471240 hasConcept C526805850 @default.
- W2980471240 hasConcept C54355233 @default.
- W2980471240 hasConcept C62203573 @default.
- W2980471240 hasConcept C67705224 @default.
- W2980471240 hasConcept C86803240 @default.
- W2980471240 hasConceptScore W2980471240C103041312 @default.
- W2980471240 hasConceptScore W2980471240C104317684 @default.
- W2980471240 hasConceptScore W2980471240C121608353 @default.
- W2980471240 hasConceptScore W2980471240C145059251 @default.
- W2980471240 hasConceptScore W2980471240C146285616 @default.
- W2980471240 hasConceptScore W2980471240C165864922 @default.
- W2980471240 hasConceptScore W2980471240C167734588 @default.
- W2980471240 hasConceptScore W2980471240C173396325 @default.
- W2980471240 hasConceptScore W2980471240C2776636583 @default.
- W2980471240 hasConceptScore W2980471240C2777025900 @default.
- W2980471240 hasConceptScore W2980471240C2779013556 @default.
- W2980471240 hasConceptScore W2980471240C2779256057 @default.
- W2980471240 hasConceptScore W2980471240C502942594 @default.
- W2980471240 hasConceptScore W2980471240C526805850 @default.
- W2980471240 hasConceptScore W2980471240C54355233 @default.
- W2980471240 hasConceptScore W2980471240C62203573 @default.
- W2980471240 hasConceptScore W2980471240C67705224 @default.